Carglumic Acid Tablet, For Suspension
Product Images NDC 71863-114

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carglumic Acid (NDC 71863-114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eton Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Booklet (Booklet)

This is a description of Carglumic Acid Tablets for oral suspension, which come in a bottle containing 60 tablets. Each tablet contains 200mg of Carglumic Acid. The package should be discarded after 90 days from the first opening. The tablets should be stored at a temperature between 20° to 25°C (68° to 77°F) and the expiry date is March 2022. The National Drug Code (NDC) for this product is 71863-114-60.*

FDA Label Image

Structure (Carglumic Structure)

FDA Label Image

Carton (Carton)

Carglumic Acid Tablets for Oral Suspension is a prescription medication that comes in a 60 tablet pack. The tablets should be dispersed in water before use and should not be swallowed whole or crushed. It is recommended to discard after 90 days from the first opening. The medication contains 200 mg Carglumic and should be kept at room temperature between 20-25 degrees Celsius. It is important to keep it out of reach of children, protect from moisture, and discard after the expiration date. Dosage and administration information can be found on the package insert.*

FDA Label Image

Figure-1 (Figure 1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.